Ikoma Minako, Liljeqvist Jan-Ake, Groen Jan, Glazenburg Koen L, The T Hauw, Welling-Wester Sytske
Department of Medical Microbiology, University of Groningen, 9713 GZ Groningen, The Netherlands.
J Clin Microbiol. 2002 Jul;40(7):2526-32. doi: 10.1128/JCM.40.7.2526-2532.2002.
Fragments of glycoprotein G (gG-2(281-594His)), comprising residues 281 to 594 of herpes simplex virus type 2 (HSV-2), glycoprotein G of HSV-1 (gG-1(t26-189His)), and glycoprotein D of HSV-1 (gD-1(1-313)), were expressed in the baculovirus expression system to develop an assay for the detection of HSV-1 and HSV-2 type-specific antibodies. The expression of the gG-1(t26-189His) and gG-2(281-594His) fragments was analyzed by Western blotting using monoclonal antibodies LP10 and AP1, respectively. The molecular masses of the major products of gG-1(t26-189His) and the fragment of gG-2(281-594His) were 36 to 39 kDa and 64 to 72 kDa, respectively. Human sera positive for HSV-1 reacted with gG-1(t26-189His), sera positive for HSV-2 reacted with the gG-2(281-594His) fragment, and sera positive for both types reacted with gG-1(t26-189His) and gG-2(281-594His) in Western blotting. The human sera recognized polypeptides of gG-2(281-594His) with molecular masses of 57 to 67 and 120 to 150 kDa and additional faint bands of 21, 29, and 45 kDa. The recombinant gG-1(t26-189His) and the recombinant gG-2(281-594His) fragment were used as type-specific antigens for the detection of HSV-1- and HSV-2-specific antibody responses in human sera, respectively. As type-common antigens, an extract of HSV-1-infected Vero cells and recombinant gD-1(1-313) were used. An enzyme-linked immunosorbent assay to detect type-specific antibodies was developed, and the sensitivity and specificity were evaluated by comparison with commercial tests by using sera obtained from different sources. The sensitivity and specificity were 91.5 and 95.5%, respectively, compared to the Gull assay. The gG-2(281-594His) fragment can be obtained in relatively large quantities at low cost.
在杆状病毒表达系统中表达单纯疱疹病毒2型(HSV-2)糖蛋白G的片段(gG-2(281 - 594His),包含281至594位残基)、HSV-1糖蛋白G(gG-1(t26 - 189His))以及HSV-1糖蛋白D(gD-1(1 - 313)),以开发一种检测HSV-1和HSV-2型特异性抗体的检测方法。分别使用单克隆抗体LP10和AP1通过蛋白质印迹法分析gG-1(t26 - 189His)和gG-2(281 - 594His)片段的表达。gG-1(t26 - 189His)主要产物和gG-2(281 - 594His)片段的分子量分别为36至39 kDa和64至72 kDa。HSV-1阳性的人血清与gG-1(t26 - 189His)反应,HSV-2阳性的血清与gG-2(281 - 594His)片段反应,两种类型均阳性的血清在蛋白质印迹法中与gG-1(t26 - 189His)和gG-2(281 - 594His)反应。人血清识别分子量为57至67 kDa和120至150 kDa的gG-2(281 - 594His)多肽以及21、29和45 kDa的其他 faint条带。重组gG-1(t26 - 189His)和重组gG-2(281 - 594His)片段分别用作检测人血清中HSV-1和HSV-2特异性抗体反应的型特异性抗原。作为型共同抗原,使用HSV-1感染的Vero细胞提取物和重组gD-1(1 - 313)。开发了一种检测型特异性抗体的酶联免疫吸附测定法,并通过与使用不同来源血清的商业检测方法进行比较来评估其敏感性和特异性。与Gull检测相比,敏感性和特异性分别为91.5%和95.5%。gG-2(281 - 594His)片段可以低成本大量获得。